INSTAPILL BIO

Serial Number 90850038
606

Registration Progress

Application Filed
Jul 27, 2021
Under Examination
Jul 28, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Feb 28, 2026 26 days
Revival assistance for abandoned trademark

Trademark Image

INSTAPILL BIO

Basic Information

Serial Number
90850038
Filing Date
July 27, 2021
Published for Opposition
May 31, 2022
Abandonment Date
December 29, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 29, 2025
Classes
005

Rights Holder

TENSHI KAIZEN PRIVATE LIMITED

99
Address
Strides House Bilekahalli
Bannerghatta Road Bangalore
Karnataka 560076
IN

Ownership History

TENSHI KAIZEN PRIVATE LIMITED

Original Applicant
99
Karnataka IN

TENSHI KAIZEN PRIVATE LIMITED

Owner at Publication
99
Karnataka IN

Legal Representation

Attorney
Zach Gordon

USPTO Deadlines

Next Deadline
26 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
February 28, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Dec 29, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 29, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 11, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 27, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 11, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 28, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 23, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 22, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 20, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 28, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 28, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 2, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 2, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
May 2, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2022 NEWN I NEW NOA TO ISSUE Loading...
Jul 26, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jul 28, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 28, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 27, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 27, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 30, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical drug delivery agents consisting of compounds in the form of pills, tablets, capsules, ointments, creams, oral suspension liquids and/or injections for the administration of medication to humans; pharmaceutical preparations and substances for the treatment and protection against infectious and autoimmune diseases; pharmaceutical parenteral preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders

Additional Information

Pseudo Mark
INSTA PILL BIO

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"